Codex Revenue and Competitors

Location

$4.5M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Codex's estimated annual revenue is currently $9.9M per year.(i)
  • Codex's estimated revenue per employee is $42,489
  • Codex's total funding is $4.5M.
  • Codex's current valuation is $221M. (January 2022)

Employee Data

  • Codex has 233 Employees.(i)
  • Codex grew their employee count by 56% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.5M190%N/AN/A
#2
$9.9M23356%$4.5M$221M
#3
$3.6M31-6%N/AN/A
Add Company

At Codex, we are committed to leveraging our unique and propriety DNA technologies into scientific solutions for accelerating and advancing research. Our ever-expanding suite of reagents and instrumentation systems are fueling novel and groundbreaking approaches for basic synthetic biology research, as well as biomedical and industrial applications. We?re converting our scientific breakthroughs into innovative products for scientists worldwide for the advancement of scientific research and drug discovery.

keywords:N/A

$4.5M

Total Funding

233

Number of Employees

$9.9M

Revenue (est)

56%

Employee Growth %

$221M

Valuation

N/A

Accelerator

Codex News

2022-04-20 - The Codex Manesse

The Codex Manesse is a richly illustrated work from the first half of the 14th century that brings together many poetic compositions of the...

2022-04-20 - The Codex Manesse

The Codex Manesse is a richly illustrated work from the first half of the 14th century that brings together many poetic compositions of the...

2022-04-20 - The Codex Manesse

The Codex Manesse is a richly illustrated work from the first half of the 14th century that brings together many poetic compositions of the...

2022-04-19 - Codex DNA Unveils Automated Synthetic Biology Solutions ...

SAN DIEGO, April 27, 2022 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (Nasdaq: DNAY), a pioneer in automated benchtop synthetic biology systems,...

2022-04-19 - Codex DNA Unveils Automated Synthetic Biology Solutions for Antibody and Protein Engineering of Biotherapeutic Targets at 18th Annual PEGS Boston Conference and Expo

Codex DNA, Inc. BioXp™ system and RapidAMP™ cell-free DNA kit allow scientists to synthesize, clone, and amplify antibody-variable regions based...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$63M233-2%N/A
#2
$51.8M233-3%N/A
#3
$3.5M23329%N/A
#4
$69.5M23426%N/A
#5
N/A234-2%N/A